X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7364) 7364
Publication (726) 726
Book Review (50) 50
Book Chapter (23) 23
Conference Proceeding (19) 19
Dissertation (19) 19
Book / eBook (7) 7
Magazine Article (5) 5
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (6226) 6226
rats (5458) 5458
rats, zucker (4376) 4376
male (3934) 3934
index medicus (2238) 2238
obesity (1958) 1958
endocrinology & metabolism (1615) 1615
obesity - metabolism (1508) 1508
female (1480) 1480
zucker rats (1274) 1274
humans (1271) 1271
mice (1151) 1151
obese zucker rats (1129) 1129
insulin resistance (1117) 1117
physiology (1056) 1056
insulin (1033) 1033
obesity - physiopathology (995) 995
insulin - blood (907) 907
diabetes (873) 873
disease models, animal (856) 856
blood glucose - metabolism (830) 830
glucose (777) 777
insulin-resistance (757) 757
biochemistry & molecular biology (745) 745
pharmacology & pharmacy (737) 737
body weight (731) 731
obesity - genetics (724) 724
rodents (713) 713
rats, sprague-dawley (676) 676
liver - metabolism (636) 636
physiological aspects (636) 636
nutrition & dietetics (633) 633
metabolism (624) 624
expression (613) 613
leptin (556) 556
rats, wistar (554) 554
glucose - metabolism (547) 547
insulin - metabolism (520) 520
type 2 diabetes (507) 507
oxidative stress (501) 501
body weight - drug effects (482) 482
neurosciences (479) 479
diet (478) 478
metabolic syndrome (468) 468
research (462) 462
gene-expression (456) 456
skeletal-muscle (444) 444
zucker rat (429) 429
hypoglycemic agents - pharmacology (425) 425
hypertension (424) 424
diabetes mellitus, type 2 - metabolism (416) 416
adipose tissue - metabolism (414) 414
food-intake (411) 411
adipose-tissue (406) 406
liver (392) 392
time factors (392) 392
muscle, skeletal - metabolism (391) 391
insulin - pharmacology (389) 389
obesity - pathology (370) 370
rna, messenger - metabolism (365) 365
obesity - complications (360) 360
gene expression (351) 351
peripheral vascular disease (347) 347
dose-response relationship, drug (345) 345
cell biology (339) 339
eating - drug effects (330) 330
glucose tolerance test (330) 330
triglycerides - blood (325) 325
body-weight (321) 321
article (320) 320
cells, cultured (315) 315
blood glucose - analysis (313) 313
insulin resistance - physiology (310) 310
brain (304) 304
obesity - blood (303) 303
obesity - drug therapy (296) 296
mice, inbred c57bl (290) 290
lipid metabolism (285) 285
diabetes mellitus, type 2 - drug therapy (283) 283
liver - drug effects (279) 279
exercise (275) 275
medicine, research & experimental (270) 270
in-vivo (269) 269
messenger-rna (266) 266
diabetes mellitus, type 2 - physiopathology (265) 265
cardiac & cardiovascular systems (263) 263
hypothalamus (263) 263
phosphorylation (258) 258
dextrose (256) 256
resistance (255) 255
hyperglycemia (254) 254
cells (253) 253
diabetes mellitus (253) 253
proteins (253) 253
fatty acids (250) 250
analysis (249) 249
health aspects (247) 247
food intake (245) 245
blood-pressure (242) 242
receptor (241) 241
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
New College (Ivey) - Stacks (2) 2
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7301) 7301
French (37) 37
Japanese (29) 29
German (14) 14
Korean (14) 14
Spanish (12) 12
Chinese (7) 7
Polish (2) 2
Portuguese (2) 2
Russian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetologia, ISSN 0012-186X, 09/2010, Volume 53, Issue 9, pp. 2008 - 2019
Reductions in peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) levels have been associated with the skeletal muscle insulin... 
Fatty acid oxidation | AS160 | Human Physiology | Metabolic Diseases | Diacylglycerol | Internal Medicine | Muscle fibres | Mitochondria | Medicine & Public Health | Triacylglycerol | Akt2 | Ceramide | FAT | GLUT4 | FATTY-ACID TRANSPORT | INCREASED EXPRESSION | MITOCHONDRIAL BIOGENESIS | ROSIGLITAZONE TREATMENT | PALMITATE OXIDATION | GLUT-4 PROTEIN | EXERCISE | MESSENGER-RNA | IN-VIVO | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | Insulin - pharmacology | RNA-Binding Proteins - genetics | Glucose Transporter Type 4 - genetics | Glucose Transporter Type 4 - metabolism | Rats | Male | Muscle, Skeletal - metabolism | Transcription Factors - genetics | Thinness - metabolism | Blotting, Western | Obesity - metabolism | Rats, Zucker | Transcription Factors - metabolism | Animals | Signal Transduction - drug effects | Muscle, Skeletal - drug effects | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | Lipid Metabolism - drug effects | Oxidation-Reduction - drug effects | Glucose - metabolism | Phosphorylation - drug effects | Fatty Acids - metabolism | RNA-Binding Proteins - metabolism | Obesity | Molecular genetics | Animal genetic engineering | Triglycerides | Mitochondrial DNA | Biosynthesis | Glucose | Insulin | Fatty acids | Dextrose | Messenger RNA | Physiological aspects | Insulin resistance | RNA | Muscles | Glucose metabolism | Genetic engineering
Journal Article
Circulation, ISSN 0009-7322, 05/2002, Volume 105, Issue 19, pp. 2296 - 2302
Background-Pioglitazone and rosiglitazone, thiazolidinedione peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activators, reduce blood pressure... 
Hypertension | Inflammation | Remodeling | Muscle, smooth | Arteries | MIGRATION | remodeling | THIAZOLIDINEDIONE | CARDIAC & CARDIOVASCULAR SYSTEMS | muscle, smooth | ZUCKER FATTY RATS | arteries | TYPE-1 RECEPTOR | INSULIN | inflammation | GENE-EXPRESSION | PPAR-GAMMA | PERIPHERAL VASCULAR DISEASE | ESSENTIAL-HYPERTENSION | ROSIGLITAZONE | HEMATOLOGY | hypertension | SMOOTH-MUSCLE CELLS | Inflammation - chemically induced | Receptors, Angiotensin - metabolism | Angiotensin II - administration & dosage | Body Weight - drug effects | Endothelium, Vascular - drug effects | Male | Thiazoles - administration & dosage | Inflammation - metabolism | Inflammation - drug therapy | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Injections, Subcutaneous | Lipids - blood | DNA - biosynthesis | Blood Pressure - drug effects | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Drug Administration Schedule | Pioglitazone | Aldosterone - blood | Rats | Cell Cycle Proteins - biosynthesis | Renin - blood | Rats, Sprague-Dawley | Blood Vessels - cytology | Cell Division - drug effects | Transcription Factors - metabolism | Collagen - metabolism | Animals | Endothelium, Vascular - metabolism | NF-kappa B - biosynthesis | Blood Vessels - drug effects | Rosiglitazone | Blood Vessels - physiology | In Vitro Techniques | Vascular Cell Adhesion Molecule-1 - metabolism | Thiazolidinediones | Receptors, Cytoplasmic and Nuclear - metabolism
Journal Article
Diabetes, ISSN 0012-1797, 11/2008, Volume 57, Issue 11, pp. 2977 - 2991
Journal Article
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 06/2012, Volume 302, Issue 12, pp. F1606 - F1615
Giani JF, Burghi V, Veiras LC, Tomat A, Munoz MC, Cao G, Turyn D, Toblli JE, Dominici FP. Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic... 
Oxidative stress | Neutrophil gelatinase-associated lipocalin | Renin-angiotensin system | Kidney | PHYSIOLOGY | neutrophil gelatinase-associated lipocalin | IKK-BETA | GELATINASE-ASSOCIATED LIPOCALIN | ISCHEMIA-REPERFUSION INJURY | kidney | INSULIN-RESISTANCE | UROLOGY & NEPHROLOGY | RECEPTOR MAS | RENAL INJURY | HYPERTENSIVE-RATS | renin-angiotensin system | oxidative stress | DISEASE PROGRESSION | Hypertriglyceridemia - drug therapy | Tumor Necrosis Factor-alpha - metabolism | Kidney - pathology | Diabetic Nephropathies - drug therapy | Angiotensin I - therapeutic use | Hypertriglyceridemia - pathology | Male | Proteinuria - pathology | Kidney - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Blood Pressure - drug effects | Interleukin-6 - metabolism | Lipocalins - metabolism | Proto-Oncogene Proteins - metabolism | Diabetic Nephropathies - pathology | Kidney - drug effects | Acute-Phase Proteins - metabolism | Diabetic Nephropathies - metabolism | Proteinuria - metabolism | Rats | Hypertriglyceridemia - metabolism | Rats, Zucker | Animals | Proteinuria - drug therapy | Fibrosis | Peptide Fragments - therapeutic use | Oxidative Stress - drug effects | Physiological aspects | Care and treatment | Angiotensin | Diabetic nephropathies | Proteins | Rodents | TNF inhibitors | Physiology | Kidney diseases | Diabetes
Journal Article
Journal of Nutrition, ISSN 0022-3166, 08/2009, Volume 139, Issue 8, pp. 1495 - 1501
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 12/2017, Volume 44, Issue 12, pp. 1263 - 1271
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 04/2010, Volume 51, Issue 4, pp. 771 - 784
The farnesoid X receptor (FXR) is a bile acid activated nuclear receptor. Zucker (fa/fa) rats, harboring a loss of function mutation of the leptin receptor,... 
RESPONSE ELEMENT | TYROSINE PHOSPHORYLATION | METABOLISM | LINKING OBESITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | DISEASE | ANIMAL-MODELS | FARNESOID-X-RECEPTOR | NONALCOHOLIC STEATOHEPATITIS | MECHANISMS | AGONISTS | Liver - pathology | Fatty Liver - pathology | Male | Muscle, Skeletal - metabolism | Insulin Receptor Substrate Proteins - metabolism | RNA, Messenger - metabolism | Thiazolidinediones - administration & dosage | Obesity - blood | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Liver - drug effects | Time Factors | Lipids - blood | Muscle, Skeletal - drug effects | Chenodeoxycholic Acid - therapeutic use | Lipid Metabolism - genetics | Phosphorylation - drug effects | Drug Therapy, Combination | Disease Models, Animal | Hypoglycemic Agents - therapeutic use | Fatty Liver - blood | Obesity - complications | Liver - metabolism | Fatty Liver - prevention & control | Insulin Resistance | Rats | Chenodeoxycholic Acid - administration & dosage | Receptors, Cytoplasmic and Nuclear - agonists | Receptors, Cytoplasmic and Nuclear - genetics | Random Allocation | Chenodeoxycholic Acid - analogs & derivatives | Gene Expression Regulation - drug effects | Rats, Zucker | Animals | Hypolipidemic Agents - administration & dosage | Lipid Metabolism - drug effects | Hypolipidemic Agents - therapeutic use | Receptors, Cytoplasmic and Nuclear - metabolism
Journal Article
Journal Article